The Race of 10 Synthetic RNAi-Based Drugs to the Pharmaceutical Market-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

The Race of 10 Synthetic RNAi-Based Drugs to the Pharmaceutical Market

Published:2017-04-07 Issue:7 Volume:34 Page:1339-1363
ISSN:0724-8741
Container-title:Pharmaceutical Research
language:en
Short-container-title:Pharm Res

Author:

Titze-de-Almeida Ricardo,David Catherine,Titze-de-Almeida Simoneide Souza

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Organic Chemistry,Pharmaceutical Science,Pharmacology,Molecular Medicine,Biotechnology

Link

http://link.springer.com/article/10.1007/s11095-017-2134-2/fulltext.html

Reference171 articles.

1. Bobbin ML, Rossi JJ. RNA interference (RNAi)-based therapeutics: delivering on the promise? Annu Rev Pharmacol Toxicol. 2016;56:103–22.

2. Martinez T, Gonzalez MV, Roehl I, Wright N, Paneda C, Jimenez AI. In vitro and in vivo efficacy of SYL040012, a novel siRNA compound for treatment of glaucoma. Mol Ther. 2014;22(1):81–91.

3. Hannon GJ. RNA interference. Nature. 2002;418(6894):244–51.

4. Hammond SM, Caudy AA, Hannon GJ. Post-transcriptional gene silencing by double-stranded RNA. Nat Rev Genet. 2001;2(2):110–9.

5. Carthew RW, Sontheimer EJ. Origins and mechanisms of miRNAs and siRNAs. Cell. 2009;136(4):642–55.

Cited by 165 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Enhancing siRNA cancer therapy: Multifaceted strategies with lipid and polymer-based carrier systems;International Journal of Pharmaceutics;2024-09

2. The advancement of siRNA-based nanomedicine for tumor therapy;Nanomedicine;2024-08-15

3. A therapeutic approach for the hepatitis C virus: in silico design of an antisense oligonucleotide-based candidate capsid inhibitor;Virus Genes;2024-07-31

4. Long non-coding RNAs: emerging functional players in the pathobiology and progression of myeloid leukemia;Frontiers in RNA Research;2024-05-31

5. Over-expression of KRT8 is associated with invasion of non-functioning pituitary adenomas;2024-05-30

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3